Kelly T. McKee - Aug 1, 2023 Form 4 Insider Report for GeoVax Labs, Inc. (GOVX)

Role: Chief Medical Officer
Signature: /s/ Kelly McKee
Stock symbol: GOVX
Transactions as of: Aug 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/14/2023, 04:50 PM
Previous filing: Jun 28, 2022
Next filing: Sep 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GOVX	Stock Option	Award	$0	+15K		$0.00	15K	Aug 1, 2023	Common Stock	15K	$0.76	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.
F2	Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant.

Content

This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.

Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant.